Berkeley's Cancer Research Lab, in close collaboration with the Cancer Research Institute, highlights June as Cancer Immunotherapy Month. "As we appreciate these events during this month, it is remarkable to reflect on how the cancer immunotherapy revolution had its roots in basic science done here in the CRL at Berkeley."
MCB Professor Michael Rape has received a 2016 Blavatnik National Awards for Young Scientists. He is recognized for his "for his fundamental discoveries related to ubiquitylation." The award comes with $250,000 in unrestricted funds, the largest award for early-career scientists in the U.S.
This $1.24 million award will be split among MCB Professor Jennifer Doudna, and her collaborator, Emmanuelle Charpentier of the Max Planck Institute of Infection Biology in Germany and Umeå University in Sweden, as well as Feng Zhang of MIT. They were awarded “for the development of CRISPR/Cas9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment.”